Abuse of New Psychoactive Substances: Threats and Solutions

There has been a recent and notable increase in the non-medical use of new psychoactive substances (NPS), or "designer drugs." Unlike classic drugs of abuse, many NPS were initially developed for research purposes. In this podcast, Drs. Michael Baumann and Nora Volkow discuss the complexities of working with these substances and how, given their genesis, research with NPS could be considered "dual use;" or, potentially utilized for both beneficial and malicious purposes.

Hosted on Acast. See acast.com/privacy for more information.

More from NPP BrainPod

  1. 09:06Ghrelin decreases sensitivity to negative feedback and increases prediction-error related caudate activity in humans, a randomized controlled trialMay 06, 2024
  2. 09:08Spotlighting SHAPERS: Sex hormones associated with psychological and endocrine rolesMar 05, 2024
  3. 09:33Comparable roles for serotonin in rats and humans for computations underlying flexible decision-makingJan 04, 2024
  4. 09:58Integrating public health and translational basic science to address challenges of xylazine adulteration of fentanylOct 16, 2023
  5. 08:29The why, when, where, how, and so what of so-called rapidly acting antidepressantsSep 06, 2023
  6. 09:09AI-based analysis of social media language predicts addiction treatment dropout at 90 daysJun 23, 2023
  7. 09:27Oxytocin effects on amygdala reactivity to angry faces in males and females with ASPDApr 21, 2023
  8. 09:54To dismantle structural racism in science, scientists need to learn how it worksFeb 22, 2023
  9. 09:59Low doses of lysergic acid diethylamide (LSD) increase reward-related brain activityDec 22, 2022
  10. 09:29Sex-dependent risk factors for PTSD: a prospective structural MRI studyNov 01, 2022